ConditionHeart & circulation

Cardiomyopathy (Heart Muscle Disease)

Cardiomyopathy is a disease of the heart muscle that makes it stretched and thin, abnormally thick or stiff, so the heart pumps or fills less efficiently. The main types are dilated, hypertrophic, restrictive and arrhythmogenic cardiomyopathy. Causes include inherited gene variants, coronary artery disease, alcohol, viral infections, pregnancy and some cancer drugs. It can cause breathlessness, fatigue, swelling, palpitations and fainting, and can lead to heart failure or dangerous rhythms. Modern treatment controls it well for most people.

Also called: Heart muscle disease, myocardial disease, weak heart muscle

At a glance

What it is
Disease of the heart muscle that impairs pumping or filling.
Main types
Dilated, hypertrophic, restrictive, arrhythmogenic, plus takotsubo and peripartum forms.
Causes
Genetic variants, coronary disease, alcohol, viral myocarditis, chemotherapy, amyloidosis, pregnancy.
Symptoms
Breathlessness, fatigue, swollen legs, palpitations, chest pain, fainting.
Diagnosis
Echocardiogram, ECG, cardiac MRI, blood tests and genetic testing.
Treatment
Heart failure medicines, rhythm control, ICDs, procedures, and transplant for advanced disease.

When to get help

Call 911 or go to the ER

  • Fainting during or right after exercise, or collapse: call 911 or your local emergency number and start CPR if the person is not breathing normally
  • Severe breathlessness at rest, pink frothy sputum, or chest pain
  • A rapid, pounding heartbeat with dizziness or near-fainting

See a doctor within a day or two

  • Breathlessness getting worse over days, or needing to sleep propped up
  • Weight gain of more than 2 to 3 lb (1 to 1.5 kg) in a day or 5 lb (2 kg) in a week with swelling
  • New palpitations or dizziness spells

Book a routine appointment

  • A family history of cardiomyopathy or sudden death under 50
  • Gradually reduced exercise tolerance, swollen ankles or unusual fatigue

Types of cardiomyopathy

TypeWhat happensCommon causes
DilatedLeft ventricle enlarges and weakens, pumping poorlyGenetic, alcohol, viral myocarditis, chemotherapy, pregnancy, unknown
HypertrophicHeart wall thickens and stiffens; may block outflowInherited sarcomere gene variants
RestrictiveMuscle becomes stiff and fills poorlyAmyloidosis, sarcoidosis, hemochromatosis, radiation
ArrhythmogenicMuscle replaced by fat and scar, causing rhythm problemsInherited desmosome gene variants
Takotsubo ("broken heart")Sudden temporary weakness after severe stressEmotional or physical stress, mostly in older women
PeripartumHeart weakens in late pregnancy or after deliveryPregnancy-related
IschemicWeak muscle from heart attacks and coronary diseaseCoronary artery disease

Strictly speaking, ischemic cardiomyopathy results from another disease, but the term is widely used.

Symptoms

Some people have no symptoms for years. When they appear:

  • breathlessness on exertion, then at rest or lying flat
  • fatigue and reduced exercise capacity
  • swelling of the ankles, legs and belly
  • palpitations or a racing, irregular heartbeat
  • chest pain, especially in hypertrophic cardiomyopathy
  • dizziness or fainting, particularly during exercise
  • sudden cardiac arrest, sometimes the first sign in young people

Causes and risk factors

  • Family history: many cardiomyopathies are inherited, usually in an autosomal dominant pattern, giving each child a 1 in 2 chance of carrying the variant.
  • Coronary artery disease and heart attacks.
  • Long-term high blood pressure and heart valve disease.
  • Alcohol and stimulant drugs such as cocaine and amphetamines.
  • Viral infections causing myocarditis.
  • Cancer treatments such as anthracyclines and trastuzumab, and chest radiation.
  • Infiltrative diseases: amyloidosis, sarcoidosis, hemochromatosis.
  • Endocrine and nutritional problems: thyroid disease, diabetes, thiamine deficiency.
  • Prolonged fast heart rhythms (tachycardia-induced cardiomyopathy), which is reversible.

Diagnosis

  • Echocardiogram: shows heart size, wall thickness and pumping (ejection fraction).
  • ECG: rhythm problems, thick walls, conduction blocks.
  • Cardiac MRI: detailed muscle characterization, scar and infiltration.
  • Blood tests: BNP or NT-proBNP for heart strain, troponin, thyroid, iron, kidney function.
  • Holter monitoring for arrhythmias.
  • Coronary angiography or CT to look for coronary disease.
  • Genetic testing and family screening: first-degree relatives are offered ECGs and echocardiograms, and gene testing if a variant is found.
  • Biopsy or specialized scans for amyloidosis or sarcoidosis.

Treatment

Medicines

  • For a weak pumping heart (heart failure with reduced ejection fraction): four core drug groups improve survival: ARNI or ACE inhibitor/ARB, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors. Diuretics relieve fluid buildup.
  • For hypertrophic cardiomyopathy: beta-blockers or calcium channel blockers, and cardiac myosin inhibitors (such as mavacamten) for obstructive forms.
  • Anticoagulants for atrial fibrillation or clots in the heart.
  • Disease-specific drugs: for example tafamidis for transthyretin amyloidosis.

Devices and procedures

  • Implantable cardioverter-defibrillator (ICD): shocks the heart out of life-threatening rhythms in people at high risk of sudden death.
  • Cardiac resynchronization therapy for weak hearts with a wide QRS.
  • Septal myectomy or alcohol septal ablation to relieve obstruction in hypertrophic cardiomyopathy.
  • Catheter ablation for some arrhythmias.
  • Left ventricular assist devices and heart transplant for advanced disease.

Living with cardiomyopathy

  • Limit salt, and follow fluid advice if given.
  • Avoid alcohol in alcohol-related or dilated cardiomyopathy, and avoid stimulant drugs.
  • Weigh yourself daily to catch fluid buildup early.
  • Stay active with a plan agreed with your cardiologist. Many people can exercise safely; guidance on competitive sport has become less restrictive for some conditions after individual assessment.
  • Get flu, COVID-19 and pneumococcal vaccines.
  • Plan pregnancy with a cardiologist.

Complications

Outlook

The outlook varies widely by type and cause. Many people with hypertrophic cardiomyopathy have a normal life expectancy with modern care. Dilated cardiomyopathy often improves substantially with medicines, and some causes, such as alcohol, tachycardia and peripartum cardiomyopathy, can partly or fully reverse. Advanced disease can be life-limiting, but devices and transplant offer options.

Frequently asked questions

What are the first signs of cardiomyopathy?

Early signs include breathlessness with activity, unusual tiredness, swollen ankles, palpitations, dizziness, and chest discomfort. Some people have no symptoms and are diagnosed after an abnormal ECG, family screening, or, rarely, after fainting or cardiac arrest.

What causes cardiomyopathy?

Causes include inherited gene variants, coronary artery disease, long-term high blood pressure, heavy alcohol use, viral infections, some chemotherapy drugs, amyloidosis, pregnancy and thyroid disease. In some people no cause is found.

Can cardiomyopathy be reversed?

Some types can improve or reverse, such as cardiomyopathy caused by alcohol, fast heart rhythms, pregnancy, stress (takotsubo) or thyroid disease. Genetic forms are lifelong but often well controlled with medicines and devices.

What is the life expectancy with cardiomyopathy?

It depends on the type, severity and response to treatment. Many people live normal or near-normal lifespans with modern medicines, devices and monitoring. Advanced heart failure carries a poorer outlook, but transplant and assist devices are options.

Is cardiomyopathy hereditary?

Many forms are, especially hypertrophic, arrhythmogenic and some dilated cardiomyopathies. If you are diagnosed, your parents, siblings and children are usually advised to have heart screening and possibly genetic testing.

Sources

This guide was written from current patient and clinical guidance, including:

  • American Heart Association: What is cardiomyopathy in adults?
  • NHLBI: Cardiomyopathy
  • European Society of Cardiology: 2023 Guidelines for the management of cardiomyopathies
  • AHA/ACC: 2024 Guideline for the management of hypertrophic cardiomyopathy
  • MedlinePlus: Cardiomyopathy